Cancer of unknown primary

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• FDG-PET is highly sensitive for detecting various carcinomas, with uptake often correlating to tumor aggressiveness.
• Interpreting FDG-PET alone for unknown primaries can yield reduced specificity due to physiological uptake in certain areas like the head and neck.
• Physiological FDG uptake in the head and neck region, particularly in lymphatic tissue and vocal cords, leads to a high rate of equivocal findings.

Purpose of the Study:

• To evaluate the utility of FDG-PET and PET/CT in localizing unknown primary tumors (CUP).
• To assess the impact of PET/CT on reducing false-equivocal and false-positive findings compared to FDG-PET alone.
• To determine the anatomical localization capabilities of PET/CT in guiding surgical intervention for CUP.

Main Methods:

• Utilized FDG-PET imaging to detect metabolic activity indicative of malignancy.
• Employed dual-modality PET/CT to correlate metabolic findings with anatomical structures.
• Analyzed the impact of CT on refining PET interpretations and detecting PET-negative findings.

Main Results:

• FDG-PET/CT can help localize the primary tumor in approximately 40% of patients with CUP.
• PET/CT reduces false-equivocal and false-positive findings by correlating suspicious PET signals with CT morphology.
• PET/CT precisely defines the anatomical site of findings, particularly valuable in the head and neck region.
• CT component of PET/CT can identify PET-negative lesions, contributing to diagnosis.

Conclusions:

• FDG-PET and PET/CT are valuable tools for localizing unknown primary tumors, even after extensive workup.
• PET/CT enhances diagnostic accuracy by integrating functional and anatomical information, improving the detection and localization of CUP.
• The anatomical precision offered by PET/CT is crucial for surgical planning, especially in complex regions like the head and neck.